Chih‐Yi Chen

8.3k total citations · 1 hit paper
117 papers, 5.0k citations indexed

About

Chih‐Yi Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chih‐Yi Chen has authored 117 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 42 papers in Pulmonary and Respiratory Medicine and 37 papers in Oncology. Recurrent topics in Chih‐Yi Chen's work include RNA modifications and cancer (25 papers), Lung Cancer Treatments and Mutations (22 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Chih‐Yi Chen is often cited by papers focused on RNA modifications and cancer (25 papers), Lung Cancer Treatments and Mutations (22 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Chih‐Yi Chen collaborates with scholars based in Taiwan, United States and China. Chih‐Yi Chen's co-authors include Ya‐Wen Cheng, Huei Lee, Yi‐Ching Wang, Gee‐Chen Chang, Jung-Ta Chen, Ruo-Kai Lin, Tzu-Chin Wu, Pan‐Chyr Yang, Jer-Wei Chang and De‐Wei Wu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Chih‐Yi Chen

116 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

2007 693 citations Gee‐Chen Chang, Chih‐Yi Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chih‐Yi Chen Taiwan	39	2.6k	1.4k	1.3k	1.1k	616	117	5.0k
Han‐Shui Hsu Taiwan	42	3.0k 1.2×	1.7k 1.2×	2.1k 1.6×	1.4k 1.2×	948 1.5×	182	6.3k
Madappa N. Kundranda United States	16	2.5k 1.0×	1.4k 1.0×	2.4k 1.8×	1.5k 1.4×	901 1.5×	66	5.8k
Ondřej Topolčan Czechia	31	1.3k 0.5×	1.0k 0.7×	1.6k 1.2×	1.1k 1.0×	622 1.0×	254	4.2k
Carlos Gil Ferreira Brazil	35	1.6k 0.6×	1.4k 1.0×	1.7k 1.3×	565 0.5×	497 0.8×	179	4.2k
Elizabeth M. Ward United States	24	1.7k 0.7×	1.6k 1.1×	2.0k 1.5×	1.3k 1.2×	935 1.5×	41	6.0k
Ali Shamseddine Lebanon	39	1.6k 0.6×	1.1k 0.7×	2.3k 1.8×	1.1k 1.0×	965 1.6×	249	5.6k
Apar Kishor Ganti United States	37	1.8k 0.7×	1.9k 1.4×	2.5k 1.9×	656 0.6×	516 0.8×	262	5.5k
Carol J. Etzel United States	37	1.4k 0.5×	1.1k 0.8×	993 0.7×	791 0.7×	664 1.1×	128	4.6k
Michele L. Coté United States	37	1.4k 0.6×	1.3k 0.9×	2.0k 1.5×	1.2k 1.1×	359 0.6×	161	5.1k
Jing Jiang China	37	1.2k 0.5×	919 0.6×	1.1k 0.9×	1.3k 1.2×	1.1k 1.8×	160	4.5k

Countries citing papers authored by Chih‐Yi Chen

Since Specialization

Citations

This map shows the geographic impact of Chih‐Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Yi Chen more than expected).

Fields of papers citing papers by Chih‐Yi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Yi Chen. The network helps show where Chih‐Yi Chen may publish in the future.

Co-authorship network of co-authors of Chih‐Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Yi Chen. A scholar is included among the top collaborators of Chih‐Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Yi Chen. Chih‐Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hwang, Hei‐Fen, Chih‐Yi Chen, Wei Li, et al.. (2019). Effects of Computerized Cognitive Training and Tai Chi on Cognitive Performance in Older Adults With Traumatic Brain Injury. Journal of Head Trauma Rehabilitation. 35(3). 187–197. 20 indexed citations

Wang, Yao-Chen, De‐Wei Wu, Tzu-Chin Wu, et al.. (2018). Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase SHP2 expression. International Journal of Biological Sciences. 14(1). 47–56. 29 indexed citations

Wu, De‐Wei, Tzu-Chin Wu, Chih‐Yi Chen, & Huei Lee. (2016). PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor–Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation. Clinical Cancer Research. 22(21). 5370–5382. 33 indexed citations

Chen, Chia‐Hung, Te‐Chun Shen, Chih‐Yi Chen, et al.. (2015). Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan. Journal of the Formosan Medical Association. 115(3). 163–170. 32 indexed citations

Sung, Wen‐Wei, Yao-Chen Wang, Po-Lin Lin, et al.. (2013). IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma. Clinical Cancer Research. 19(15). 4092–4103. 61 indexed citations

Wu, Tzu-Chin, Yao-Chen Wang, Ya‐Wen Cheng, et al.. (2013). Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression. Carcinogenesis. 34(11). 2655–2663. 39 indexed citations

Fang, Hsin-Yuan, et al.. (2012). Consistently lower narcotics consumption after video-assisted thoracoscopic surgery for early stage non-small cell lung cancer when compared to open surgery: a one-year follow-up study. European Journal of Cardio-Thoracic Surgery. 43(4). 783–786. 13 indexed citations

Wu, Tzu-Chin, Shwn-Huey Shieh, Yi‐Hui Wu, et al.. (2012). MnSOD Promotes Tumor Invasion via Upregulation of FoxM1–MMP2 Axis and Related with Poor Survival and Relapse in Lung Adenocarcinomas. Molecular Cancer Research. 11(3). 261–271. 39 indexed citations

Yang, Shi‐Yi, Tsung‐Ying Yang, Kun‐Chieh Chen, et al.. (2011). EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients. Clinical Cancer Research. 17(8). 2149–2158. 26 indexed citations

10.

Wu, De‐Wei, et al.. (2011). Reduced p21WAF1/CIP1 via Alteration of p53-DDX3 Pathway Is Associated with Poor Relapse-Free Survival in Early-Stage Human Papillomavirus–Associated Lung Cancer. Clinical Cancer Research. 17(7). 1895–1905. 88 indexed citations

11.

Sung, Wen‐Wei, Yao-Chen Wang, Ya‐Wen Cheng, et al.. (2011). A Polymorphic −844T/C in FasL Promoter Predicts Survival and Relapse in Non–Small Cell Lung Cancer. Clinical Cancer Research. 17(18). 5991–5999. 55 indexed citations

12.

Wu, De‐Wei, Ya‐Wen Cheng, John Wang, Chih‐Yi Chen, & Huei Lee. (2010). Paxillin Predicts Survival and Relapse in Non–Small Cell Lung Cancer by MicroRNA-218 Targeting. Cancer Research. 70(24). 10392–10401. 117 indexed citations

13.

Wu, Yi‐Hui, Tzu-Chin Wu, Jiunn‐Wang Liao, et al.. (2010). p53 Dysfunction by Xeroderma Pigmentosum Group C Defects Enhance Lung Adenocarcinoma Metastasis via Increased Mmp1 Expression. Cancer Research. 70(24). 10422–10432. 27 indexed citations

14.

Hsu, Nan‐Yung, Jeng-Yuan Wu, Xiyong Liu, et al.. (2010). p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer. Oncology Letters. 1(4). 609–613. 8 indexed citations

15.

Chien, Chun‐Ru, Chih‐Yi Chen, Hsin-Yuan Fang, et al.. (2010). Impact of the New Lung Cancer Staging System for a Predominantly Advanced-Disease Patient Population. Journal of Thoracic Oncology. 5(3). 340–343. 9 indexed citations

16.

Yu, Yang-Hao, Chien‐Chang Liao, Wu-Huei Hsu, et al.. (2010). Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort Study. Journal of Thoracic Oncology. 6(1). 32–37. 170 indexed citations

17.

Cheng, Ya‐Wen, Ming‐Fang Wu, John Wang, et al.. (2007). Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation. Cancer Research. 67(22). 10686–10693. 112 indexed citations

18.

Chang, Gee‐Chen, Ko‐Jiunn Liu, Chia‐Ling Hsieh, et al.. (2006). Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clinical Cancer Research. 12(19). 5746–5754. 128 indexed citations

19.

Hsu, Wu-Huei, Chi‐Der Chiang, Chih‐Yi Chen, et al.. (1998). Color Doppler ultrasound pulsatile flow signals of thoracic lesions: comparison of lung cancers and benign lesions. Ultrasound in Medicine & Biology. 24(8). 1087–1095. 26 indexed citations

20.

Hsu, Wu‐Huei, et al.. (1995). Ultrasound‐guided fine‐needle aspiration biopsy of solitary pulmonary nodules. Journal of Clinical Ultrasound. 23(9). 531–536. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact